Techno Drugs Ltd. (DSE:TECHNODRUG)
 31.80
 -0.60 (-1.85%)
  At close: Nov 4, 2025
Techno Drugs Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
 Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year  | TTM | FY 2024 | FY 2023 | FY 2022 | 
|---|---|---|---|---|
Period Ending  | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | 
Cash & Equivalents     | 373.69 | 321.08 | 34.47 | 139.94 | 
Short-Term Investments     | 31.71 | 47.34 | 53.22 | 30.6 | 
Cash & Short-Term Investments     | 405.4 | 368.42 | 87.69 | 170.53 | 
Cash Growth     | 362.31% | 320.15% | -48.58% | - | 
Accounts Receivable     | 1,208 | 958.96 | 789.71 | 707.18 | 
Other Receivables     | - | 41.04 | 41.04 | 41.04 | 
Receivables     | 1,208 | 1,000 | 830.76 | 748.22 | 
Inventory     | 1,084 | 856.87 | 939.14 | 646.64 | 
Prepaid Expenses     | - | 4.54 | 5.55 | 4.27 | 
Other Current Assets     | 733.09 | 397.74 | 352.6 | 299.12 | 
Total Current Assets     | 3,430 | 2,628 | 2,216 | 1,869 | 
Property, Plant & Equipment     | 3,886 | 3,869 | 3,818 | 3,492 | 
Long-Term Investments     | 0.27 | 0.27 | 0.27 | 0.27 | 
Other Intangible Assets     | 5.7 | 6.39 | 7.22 | 3.09 | 
Total Assets     | 7,322 | 6,503 | 6,041 | 5,364 | 
Accounts Payable     | 156.48 | 76.72 | 78.06 | 65.92 | 
Accrued Expenses     | 80.35 | 155.74 | 186.26 | 148.25 | 
Short-Term Debt     | 657.02 | 920.1 | 1,188 | 854.58 | 
Current Portion of Long-Term Debt     | 421.23 | 509.8 | 414.02 | 474.44 | 
Current Portion of Leases     | 27.95 | 40.78 | 27.76 | 21.27 | 
Current Income Taxes Payable     | 226.72 | 179.1 | 215.27 | 162.21 | 
Current Unearned Revenue     | - | 12.32 | 3.22 | - | 
Other Current Liabilities     | 9.67 | 16.29 | 11.49 | 7.54 | 
Total Current Liabilities     | 1,579 | 1,911 | 2,124 | 1,734 | 
Long-Term Debt     | 1,532 | 1,212 | 1,056 | 973.76 | 
Long-Term Leases     | 57.08 | 57.1 | 32.92 | 32.19 | 
Long-Term Deferred Tax Liabilities     | 162.32 | 168.41 | 216.49 | 191.45 | 
Other Long-Term Liabilities     | - | - | -0 | -0 | 
Total Liabilities     | 3,330 | 3,348 | 3,429 | 2,932 | 
Common Stock     | 1,320 | 941.57 | 941.57 | 941.57 | 
Retained Earnings     | 1,563 | 1,464 | 1,183 | 987.83 | 
Comprehensive Income & Other     | 487.44 | 748.98 | 487.44 | 502.99 | 
Shareholders' Equity     | 3,992 | 3,154 | 2,612 | 2,432 | 
Total Liabilities & Equity     | 7,322 | 6,503 | 6,041 | 5,364 | 
Total Debt     | 2,695 | 2,740 | 2,718 | 2,356 | 
Net Cash (Debt)     | -2,289 | -2,371 | -2,630 | -2,186 | 
Net Cash Per Share     | -18.53 | -24.85 | -27.94 | -23.21 | 
Filing Date Shares Outstanding     | 132 | 94.16 | 94.16 | 94.16 | 
Total Common Shares Outstanding     | 132 | 94.16 | 94.16 | 94.16 | 
Working Capital     | 1,851 | 716.73 | 91.79 | 134.58 | 
Book Value Per Share     | 30.24 | 33.50 | 27.74 | 25.83 | 
Tangible Book Value     | 3,986 | 3,148 | 2,605 | 2,429 | 
Tangible Book Value Per Share     | 30.20 | 33.43 | 27.67 | 25.80 | 
Land     | - | 770.52 | 770.52 | 769.57 | 
Buildings     | - | 2,154 | 1,877 | 1,686 | 
Machinery     | - | 2,468 | 2,353 | 2,050 | 
Construction In Progress     | - | 132.73 | 179.88 | 49.64 | 
Source: S&P Global Market Intelligence. Standard template. Financial Sources.